BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
Follow-Up Questions
BLLSF の株価パフォーマンスは？
BLLSF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Biolight Life Sciences Ltd の主な事業テーマや業界は？
Biolight Life Sciences Ltd は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
